Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-25-003450
Filing Date
2025-03-27
Accepted
2025-03-27 17:00:24
Documents
102
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0234394-10k_oramed.htm   iXBRL 10-K 2044768
2 FIFTH AMENDED AND RESTATED BY-LAWS, ADOPTED EFFECTIVE MARCH 27, 2025 ea023439401ex3-2_oramed.htm EX-3.2 124134
3 FIFTH AMENDED AND RESTATED BY-LAWS, ADOPTED EFFECTIVE MARCH 27, 2025 (MARKED COP ea023439401ex3-3_oramed.htm EX-3.3 123924
4 DESCRIPTION OF SECURITIES ea023439401ex4-2_oramed.htm EX-4.2 18572
5 AMENDMENT, DATED NOVEMBER 7, 2024, TO EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED ea023439401ex10-72_oramed.htm EX-10.72 8225
6 AMENDMENT, DATED NOVEMBER 7, 2024, TO EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED ea023439401ex10-73_oramed.htm EX-10.73 6601
7 AMENDMENT, DATED NOVEMBER 7, 2024, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAME ea023439401ex10-74_oramed.htm EX-10.74 8405
8 ORAMED PHARMACEUTICALS INC. INSIDER TRADING POLICY ea023439401ex19-1_oramed.htm EX-19.1 62854
9 SUBSIDIARIES ea023439401ex21-1_oramed.htm EX-21.1 1575
10 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER ea023439401ex23-1_oramed.htm EX-23.1 2433
11 CERTIFICATION ea023439401ex31-1_oramed.htm EX-31.1 9729
12 CERTIFICATION ea023439401ex31-2_oramed.htm EX-31.2 9752
13 CERTIFICATION ea023439401ex32-1_oramed.htm EX-32.1 3172
14 CERTIFICATION ea023439401ex32-2_oramed.htm EX-32.2 3165
15 GRAPHIC image_001.jpg GRAPHIC 4982
16 GRAPHIC ex19-1_001.jpg GRAPHIC 2260
  Complete submission text file 0001013762-25-003450.txt   9840758

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE ormp-20241231.xsd EX-101.SCH 77987
18 XBRL CALCULATION FILE ormp-20241231_cal.xml EX-101.CAL 52112
19 XBRL DEFINITION FILE ormp-20241231_def.xml EX-101.DEF 371238
20 XBRL LABEL FILE ormp-20241231_lab.xml EX-101.LAB 706893
21 XBRL PRESENTATION FILE ormp-20241231_pre.xml EX-101.PRE 399674
104 EXTRACTED XBRL INSTANCE DOCUMENT ea0234394-10k_oramed_htm.xml XML 1236281
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35813 | Film No.: 25780273
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)